LISA MCDONALD: Open Payments
NPI 1770691016 · ELLENBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 78 payments from 17 companies in 2025. Trend: 2023 $50 · 2024 $755 · 2025 $1,575
Food & beverage: $1,575
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $388 |
| Otsuka America Pharmaceutical, Inc. | 14 | $202 |
| GlaxoSmithKline, LLC. | 7 | $162 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Bioventus LLC | 1 | $94 |
| Lilly USA, LLC | 4 | $77 |
| Amgen Inc. | 4 | $75 |
| Alkermes, Inc. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Verona Pharma, Inc. | 2 | $59 |
Products named: REXULTI, VRAYLAR, QULIPTA, TRELEGY ELLIPTA, DUROLANE, AIRSUPRA, MOUNJARO, ARISTADA.
Industry payments across NY — which companies pay providers there.
